Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

2.94
Delayed Data
As of Sep 23
 +0.24 / +8.89%
Today’s Change
1.24
Today|||52-Week Range
3.46
+55.56%
Year-to-Date
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
Why Polaris Industries, Amarin, and VimpelCom Slumped Today
Sep 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.70
Today’s open2.67
Day’s range2.65 - 2.97
Volume4,197,034
Average volume (3 months)2,838,758
Market cap$613.9M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)+207.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.03+0.19%
ARWRArrowhead Pharmaceut...-0.05-0.69%
RGNXRegenxbio Inc-0.50-3.31%
BSTCBiospecifics Technol...+1.22+2.77%
Data as of 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs